VAERS reports by lot

GSK Varicella/Shingles lot 47JA3: VAERS reports

48 VAERS reports list lot 47JA3 as a GSK Varicella/Shingles vaccine, received between 2019-04-16 and 2020-12-30. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
48
Reports
0%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction4225%
General / Systemic (non-local)3722%
Musculoskeletal2213%
Dermatological (non-injection-site)2012%
Allergic / Anaphylactic1710%
Cardiac / Cardiovascular85%
Neurological74%
Gastrointestinal74%
Respiratory32%
Thrombotic / Hematological11%
Autoimmune / Immune-mediated11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California5
Texas4
Georgia4
Ohio4
Missouri4
Pennsylvania2
Kansas2
Arizona2
Arkansas2
Louisiana2
Iowa2
Washington2

Reports by month received

2019-047
2019-0518
2019-0610
2019-075
2019-083
2019-111
2019-122
2020-021
2020-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.